2025 Partners

EMD Serono

Website: https://www.emdserono.com/us-en

At EMD Serono, we’re committed to connecting important details within the fertility cycle. Thanks to our long-standing expertise, support programs, and partnerships, we aim to provide patients with solutions that can help ART treatment success.

To Learn more about our commitment to financial affordability and access for our fertility medications, please visit www.fertilitysavings.com.

To learn more about our fertility medication portfolio, please visit www.emdseronofertility.com.

Bayer

Website: https://www.bayer.com/en/

Bayer is a recognized leader in the area of women’s healthcare, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments. Bayer offers a wide range of effective short- and long-acting birth control methods as well as therapies for menopause management and gynecological diseases. Bayer is also focusing on innovative options to address the unmet medical needs of women worldwide. Today, Bayer’s research and development efforts focus on finding new treatment options for menopause as well as gynecological diseases and includes several compounds in various stages of pre-clinical and clinical development. Together, these projects reflect the company’s approach to research, which prioritizes targets and pathways with the potential to alter the way that gynecological diseases are treated. Additionally, Bayer intends to provide 100 million women in low-and-middle income countries by 2030 with access to family planning by funding multi-stakeholder aid programs and by ensuring the supply of affordable modern contraceptives. This is part of the comprehensive sustainability measures and commitments from 2020 onwards and in line with the Sustainable Development Goals of the United Nations.

GenBioPro

Website: https://genbiopro.com/

GenBioPro is changing the landscape for reproductive health. We are a new and different kind of pharmaceutical company, determined to make a difference. Our mission and values are straightforward: we stand for personal dignity, access to medical evidence, self-determination, and a world that ensures that safe, affordable, reproductive health care — including medical abortion — is within reach for everyone.

Mira

Website: https://www.miracare.com/

Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing for over 92,000 customers. In 2023, they were recognized by Inc. 5000 as America's fastest-growing femtech company.

Mira’s most important breakthrough was inventing the market's only FDA-compliant at-home fertility monitor with quantitative technology. Since the beginning, they have been on a mission to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives—from the menstrual stage to menopause.

Mira offers solutions to test, boost, and navigate fertility—starting from comprehensive hormone testing and supplements to fertility coaching and online courses. Unlike conventional at-home test kits, the Mira Hormone Monitor offers AI-powered personalized cycle insights by continuously monitoring four key hormone concentrations in urine samples. Mira’s certified lab test equips these insights with additional biomarkers, by offering personalized, one-on-one medical care and coaching to support every stage of their patients’ journeys with actionable steps. This type of test reveals a considerable amount of data, including a 6-day fertile window and ovulation day, and helps detect useful insights for people with hormone imbalances or signs of menopause. For those on a fertility journey, the Mira Hormone Monitor helped 84% of patients conceive during the first 6 cycles.

Plus, OB/GYNs, REIs, and Integrative and Functional medicine practitioners widely rely on Mira for continuous hormone data in addition to incorporating other standard-of-care measures, revolutionizing diagnostic decisions while lowering costs and improving outcomes. Mira leverages 11 million anonymous hormonal data points and 850,000 menstrual cycles to fill gaps in women’s healthcare and reveal how sex hormones affect broader health conditions to be ****better studied, diagnosed, and understood.

Venable LLP

Website: https://www.venable.com/

Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, high-net-worth entrepreneurs, and other individuals. With more than 850 professionals across the country, including in California, Colorado, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the United States and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit https://www.venable.com/

Organon

Website: https://www.organon.com/

Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.

Restful Pump

Website: https://restfulpump.com/

Founded by a mom, for moms, Restful Pump’s mission is to improve the breast pumping

experience with the world’s first forward leaning, ergonomic, hands-free lactation systems.

Clinical research using randomized internally controlled study subjects increased total

breast milk expression with documented increased breast milk flow rates using The

Restful Pump® Chair.

For lactating moms experiencing sleep deprivation, exhaustion, chronic fatigue, and or

seeking postpartum restoration, there is a better way, even if a pump is worn inside the

bra. Offering corrective ergonomic positioning systems mitigates chronic strains from poor

postures, encourages relaxation and leaning forward facilitates gravity.

Using a breast pump to capture vital nutrients for infants unable to latch efficiently due to

tongue ties, lip ties, being a preemie or other medical complications, is a medical necessity.

Breast pumps are used 2-4x or even up to 10-12x a day! With caring for the family during

the day, working, and pumping in the middle of the night, when is Mom supposed to rest?

With Restful Pump®, we support busy, exhausted moms and care about the quality of life

for moms and their families.

Restful Pump® is addressing globally overlooked problems with simple, inexpensive

solutions. Now women can rest, unwind, or multitask in a supportive hands-free position,

using any type of breast pump. While providing comfort, convenience, and productivity,

our devices may even negate the need for baby formula by extending the breastfeeding

journey.

Our life changing patented/patent pending devices aim to dramatically improve the

efficacy and comfort of the breast pump experience, decrease medical expenses, increase

milk availability for NICU/NEC infants, expediting hospital discharge for new moms and

their infants. What formula shortage? We didn’t notice.

Restful Pump’s groundbreaking innovations will unequivocally and positively impact

maternal wellness and infant health. Because no one should (hypothetically) have PTSD

from seeing a breast pump and we can do better for ourselves and our babies, globally.

Solarea Bio

Website: https://solareabio.com/

Solarea Bio is a pioneering biotech company that harnesses natural, food-derived microbes to create innovative health solutions for chronic inflammatory conditions. As it enters the commercial stage, Solarea Bio is launching Journa™, a new consumer health brand, to bring its groundbreaking science to market. Journa's debut product, Bondia™, is a synbiotic medical food for the dietary management of bone loss associated with menopause, age and weight, demonstrating improvements in femur and hip bone density. Bondia is the first in a series of innovative microbe-powered products designed to address critical unmet needs in women’s health.